US 11,655,210 B2
Compound for improving L-arginine bioavailability
Maurizio Fava, Newton, MA (US); and Xudong Huang, Andover, MA (US)
Assigned to The General Hospital Corporation, Boston, MA (US)
Appl. No. 17/56,521
Filed by The General Hospital Corporation, Boston, MA (US)
PCT Filed May 20, 2019, PCT No. PCT/US2019/033064
§ 371(c)(1), (2) Date Nov. 18, 2020,
PCT Pub. No. WO2019/222726, PCT Pub. Date Nov. 21, 2019.
Claims priority of provisional application 62/673,328, filed on May 18, 2018.
Prior Publication US 2021/0206717 A1, Jul. 8, 2021
Int. Cl. C07C 279/12 (2006.01)
CPC C07C 279/12 (2013.01) 6 Claims
1. A compound, which is:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.